Ellen Laber

Ellen Laber is an experienced medical writing consultant with a strong background in preparing and managing clinical and regulatory documents for various phases of regulatory drug submissions, including INDs, NDAs, and MAAs. Current roles as an Independent Consultant Medical Writer at BigHat Biosciences and previous positions at Pfizer, Mineralys Therapeutics, and Seagen highlight expertise in editing and strategic guidance across cross-functional teams. Prior experience includes leadership roles at Sienna Biopharmaceuticals and Allergan Pharmaceuticals, where Ellen Laber directed medical writing efforts and developed document standards. With a PhD in Organic Chemistry from UC San Diego and a postdoctoral fellowship from Stanford University, Ellen Laber possesses a solid scientific foundation to inform regulatory strategies and document quality assurance.